Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SOX vs XELOX in Peritoneal Metastasis of Colorectal Cancer
NCT02870153Phase 2Unknown
- Sponsor
- Changzhou First People's Hospital
- Start
- Jan 2013
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tegafur in colorectal cancer (CRC), sponsored by Changzhou First People's Hospital. Status: unknown.
02
Drugs
tegafur
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT02870153.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02870153.